Work

Identification and characterisation of Mnk inhibitors as potential ant-cancer agents

Year: 2017
Type: dissertation
Abstract: There is a growing interest in mitogen-activated protein kinase (MAPK)-interacting kinases 1 and 2 (Mnk1 and Mnk2) as anti-cancer targets. Mnks integrate signals from several oncogenic and immune signalling pathways, including Ras/Raf/ERK, PI3K/AKT/mTOR, p38 and Toll-like receptor (TLR) pathways, by phosphorylating the eukaryotic initiation factor 4E (eIF4E) and other key effector proteins including heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1), sprouty 2 and the polypyrimidine tract-binding protein-associated splicing factor (PSF). Through phosphorylation of these regulatory proteins, Mnks selectively regulate the stability and translation of a subset of cellular mRNAs. This thesis focused on the identification and characterisation of novel Mnk inhibitors, which can be used to gain pharmacological proof of concept for this anti-cancer strategy. For this purpose, a comprehensive profiling platform was developed with enzymatic and cellular assays.
Language: English
Open Access status: green
OpenAlex ID: W7222379176
Cites: 193
Cited by:
Related to: 9